Dergiler / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 5

The prevalence of IgG4-positive plasma cell infiltrates in inflammatory bowel disease patients without autoimmune pancreatitis

Sayfa
558–562
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Together, these two parameters indicate the possible diagnosis of an IgG4-related systemic disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: IgG4-related autoimmune disease can exist in other organs even when there is no evidence of autoimmune pancreatitis.
📊
Temel Bulgular & Veri:The aim of our study was to determine the prevalence of IgG4-positive plasma cells in the histopathological evaluations of colon biopsy specimens in IBD patients.
💡
Sonuç & Katkı:Together, these two parameters indicate the possible diagnosis of an IgG4-related systemic disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: IgG4-related autoimmune disease can exist in other organs even when there is no evidence of autoimmune pancreatitis. The aim of our study was to determine the prevalence of IgG4-positive plasma cells in the histopathological evaluations of colon biopsy specimens in IBD patients. Materials and Methods: The number of IgG4-positive plasma cells with strong cytoplasmic immunoreactivity was counted in each colon biopsy from inflammatory bowel disease patients who had no evidence of autoimmune pancreatitis. Five high power fields (HPFs) in the highest density plasma cell infiltration area were counted and were then averaged. An average >10 cells/HPF was considered significant for IgG4-related disease. Results: We detected IgG4-positive plasma cell staining in the colon of 21 of 119 patients (17.6%). Of these 21 patients, 5 had elevated serum IgG4 levels (>140 mg/dL). Of the total, 4.2% (5/119) had both IgG4-immunstaining and elevated IgG4 serum levels. The demographic features, disease type and activity, and response to treatment (especially to steroid treatment) were similar between the IgG4-negative and IgG4-positive groups.Conclusion: In our study, 4.2% of patients with the diagnosis of IBD had elevated IgG4 serum levels and significant IGg4 immunostaining. Together, these two parameters indicate the possible diagnosis of an IgG4-related systemic disease.

🔖

Bu Makaleye Atıf Yap

TOPAL, F., SARITAŞ, E. Y., EKİNCİ, N., PEKDİKER, M., ÇAKALAĞAOĞLU, F., ALPER, E., ÜNSAL, B. (2014). The prevalence of IgG4-positive plasma cell infiltrates in inflammatory bowel disease patients without autoimmune pancreatitis. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 5, 558–562. https://ajindex.com/articles/409547

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plas- ma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 2011; 64: 237-43.
  2. Narula N, Vasudev M, Marshall JK. IgG(4)-related sclerosing dis- ease: a novel mimic of inflammatory bowel disease. Dig Dis Sci 2010; 55: 3047-51.
  3. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
  4. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003; 98: 2811-2.
  5. Kamisawa T, Matsukawa M, Amemiya K, et al. Pancreatitis associ- ated with pancreaticobiliary maljunction. Hepatogastroenterol- ogy 2003; 50: 1665-8.
  6. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005; 31: 28-31.
  7. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Vir- chows Arch 2004; 445: 552-63.
  8. Rebours V, Le Baleur Y, Cazals-Hatem D, et al. Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis. Clin Gastro- enterol H 2012; 10: 91-4.
  9. Ravi K, Chari ST, Vege SS, Sandborn WJ, Smyrk TC, Loftus EV Jr. In- flammatory bowel disease in the setting of autoimmune pancre- atitis. Inflamm Bowel Dis 2009; 15: 1326-30.
  10. Barthet M, Hastier P, Bernard JP, et al. Chronic pancreatitis and in- flammatory bowel disease: true or coincidental association? Am J Gastroenterol 1999; 94: 2141-8.
  11. Shen B, Bennett AE, Navaneethan U. IgG4-associated pouchitis. Inflamm Bowel Dis 2011; 17: 1247-8.
  12. Bosco JJ, Suan D, Varikatt W, Lin MW. Extra-pancreatic manifesta- tions of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression. Internal medi- cine journal 2013; 43: 417-23.
  13. Stone JH, Zen Y, Deshpande V. IgG4-related disease. New Engl J Med 2012; 366: 539-51.
  14. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14: 3948-55.
  15. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: Analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68: 1310-5.
  16. Chari ST, Smyrk TC, Levy MJ